SPOTLIGHT: Market expands for infectious diseases


An increasing amount of global travel has caused several infectious diseases, such as Yellow Fever and West Nile Virus, to surface in developed countries after largely being restricted to underdeveloped areas. And that trend has opened up a channel for vaccine manufacturers to develop products for advanced countries. Release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.